April Kelly Scott Salama, MD

Publications

Tan, I, Malinzak, M, and Salama, AKS. "Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy." Journal for Immunotherapy of Cancer 6, no. 1 (July 31, 2018): 77-null.

PMID
30064495
Full Text

Sammons, S, McNamara, M, Salama, AKS, and Crawford, J. "Immune checkpoint inhibition." In Side Effects of Medical Cancer Therapy: Prevention and Treatment: Second Edition, 315-353. June 27, 2018.

Full Text

Barker, CA, and Salama, AK. "New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma." Journal of the National Comprehensive Cancer Network : Jnccn 16, no. 5S (May 2018): 646-650.

PMID
29784747
Full Text

Maio, M, Lewis, K, Demidov, L, Mandalà, M, Bondarenko, I, Ascierto, PA, Herbert, C, Mackiewicz, A, Rutkowski, P, Guminski, A, Goodman, GR, Simmons, B, Ye, C, Yan, Y, Schadendorf, D, Cinat, G, Fein, LE, Brown, M, Haydon, A, Khattak, A, McNeil, C, Parente, P, Power, J, Roberts-Thomson, R, Sandhu, S, Underhill, C, Varma, S, Berger, T, Awada, A, Blockx, N, Buyse, V, Mebis, J, Franke, FA, Jobim de Azevedo, S, Silva Lazaretti, N, Jamal, R, Mihalcioiu, C, Petrella, T, Savage, K, Song, X, Wong, R, Dabelic, N, Plestina, S, Vojnovic, Z, Arenberger, P, Kocak, I, Krajsova, I, Kubala, E, Melichar, B, Vantuchova, Y, Putnik, K, Dreno, B, Dutriaux, C, Grob, J-J, Joly, P, Lacour, J-P, Meyer, N, Mortier, L, Thomas, L, Fluck, M, Gambichler, T, Hassel, J, Hauschild, A, Donnellan, P, McCaffrey, J, Power, D, Ariad, S, Bar-Sela, G, Hendler, D, Ron, I, Schachter, J, Ascierto, P, Berruti, A, Bianchi, L, Chiarion Sileni, V, Cognetti, F, Danielli, R, Di Giacomo, AM, Gianni, L, Goldhirsch, A, Guida, M, Marchetti, P, Queirolo, P, Santoro, A, Kapiteijn, E, Ferreira, P, Gafton, G, Makarova, Y, Andric, Z, Babovic, N, Jovanovic, D, Kandolf Sekulovic, L, Cohen, G, Dreosti, L, Vorobiof, D, Curiel Garcia, MT, Diaz Beveridge, R, Majem Tarruella, M, Marquez Rodas, I, Puliats Rodriguez, J-M, Rueda Dominguez, A, Maroti, M, Papworth, K, Michielin, O, Brown, E, Corrie, P, Harries, M, Kumar, S, Martin-Clavijo, A, Middleton, M, Patel, P, Talbot, T, Agarwala, S, Chapman, P, Conry, R, Doolittle, G, Gangadhar, T, Hallmeyer, S, Hamid, O, Hernandez-Aya, L, Johnson, D, Kass, F, Kolevska, T, Lunin, S, Salama, A, Sikic, B, Somer, B, Spigel, D, and Whitman, E. "Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial." The Lancet Oncology 19, no. 4 (April 2018): 510-520.

Full Text

Clarke, JM, George, DJ, Lisi, S, and Salama, AKS. "Immune Checkpoint Blockade: The New Frontier in Cancer Treatment." Targeted oncology 13, no. 1 (February 13, 2018): 1-20.

PMID
29441437
Full Text

Bhatti, MT, and Salama, AKS. "Neuro-ophthalmic side effects of molecularly targeted cancer drugs." Eye (London, England) 32, no. 2 (February 2018): 287-301. (Review)

PMID
29052609
Full Text

Hamid, O, Puzanov, I, Dummer, R, Schachter, J, Daud, A, Schadendorf, D, Blank, C, Cranmer, LD, Robert, C, Pavlick, AC, Gonzalez, R, Hodi, FS, Ascierto, PA, Salama, AKS, Margolin, KA, Gangadhar, TC, Wei, Z, Ebbinghaus, S, Ibrahim, N, and Ribas, A. "Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma." European Journal of Cancer (Oxford, England : 1990) 86 (November 2017): 37-45.

PMID
28961465
Full Text

Gangadhar, TC, Hwu, W-J, Postow, MA, Hamid, O, Daud, A, Dronca, R, Joseph, R, O'Day, SJ, Hodi, FS, Pavlick, AC, Kluger, H, Oxborough, RP, Yang, A, Gazdoiu, M, Kush, DA, Ebbinghaus, S, and Salama, AKS. "Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program." Journal of Immunotherapy (Hagerstown, Md. : 1997) 40, no. 9 (November 2017): 334-340.

PMID
29028788
Full Text

Beasley, GM, Hu, Y, Youngwirth, L, Scheri, RP, Salama, AK, Rossfeld, K, Gardezi, S, Agnese, DM, Howard, JH, Tyler, DS, Slingluff, CL, and Terando, AM. "Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study." Annals of Surgical Oncology 24, no. 9 (September 2017): 2728-2733.

PMID
28508145
Full Text

Turner, MC, Rossfeld, K, Salama, AKS, Tyler, D, and Beasley, G. "Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?." Expert opinion on pharmacotherapy 18, no. 5 (April 2017): 487-495. (Review)

PMID
28277830
Full Text

Pages